Recession USA 2020

Metacrine prices IPO at $13 (Pending:MTCR)

Metacrine (MTCR) has priced its IPO of 6.54M at $13.00/share, for expected gross proceeds of ~$85M.

Underwriters’ over-allotment is an additional 981K shares.

Trading kicks off September 16. Closing date is September 18.

Previously: Metacrine sets IPO terms (Sept. 9)

Related posts

CooTek EPS beats by $0.02, beats on revenue

Army Corps seeks reversal of Dakota Access pipeline ruling (NYSE:ET)

A new executive order escalates Trump’s attack on H-1B visas for foreign workers

Leave a Comment